BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 7805704)

  • 21. Piroxicam-beta-cyclodextrin: effects on gastrointestinal blood loss and gastric mucosal appearance in healthy men.
    Warrington S; Debbas N; Farthing M; Horton M; Umile A
    Int J Tissue React; 1991; 13(5):243-8. PubMed ID: 1806546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and tolerability of tenoxicam--an overview.
    Vischer TL
    Eur J Rheumatol Inflamm; 1987; 9(2):51-7. PubMed ID: 3329109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and tolerability of tenoxicam--an overview.
    Vischer TL
    Scand J Rheumatol Suppl; 1987; 65():107-12. PubMed ID: 3317800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Double-blind randomized multicenter study with tenoxicam, piroxicam and diclofenac sodium retard in the treatment of ambulatory patients with arthroses and soft tissue rheumatism].
    Moser U; Waldburger M; Schwarz HA; Gobelet CA
    Schweiz Rundsch Med Prax; 1989 Mar; 78(10):263-9. PubMed ID: 2649954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A double-blind randomised multicentre study with tenoxicam, piroxicam and diclofenac sodium retard in the treatment of ambulant patients with osteoarthritis and extra-articular rheumatism.
    Moser U; Waldburger H; Schwarz HA; Gobelet CA
    Scand J Rheumatol Suppl; 1989; 80():71-80. PubMed ID: 2688081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical experiences with tenoxicam. Preliminary results of a multicenter study].
    Marcolongo R; Fioravanti A
    Recenti Prog Med; 1991 Apr; 82(4):242-9. PubMed ID: 1857847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double-blind parallel study of tenoxicam and piroxicam in patients with osteoarthrosis.
    Bird HA; Hill J; Dixon JS; Looi D; Wright V
    Eur J Rheumatol Inflamm; 1985; 8(1):53-9. PubMed ID: 3915888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multicentre study of tenoxicam for the treatment of osteo-arthritis and rheumatoid arthritis in general practice.
    Langdon CG; Moran DG; Jamieson V; Spence S; Hill SA
    J Int Med Res; 1990; 18(6):489-96. PubMed ID: 2292331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double-blind comparison of etodolac and piroxicam in the treatment of rheumatoid arthritis.
    Dick WC; Franchimont P; Veys E
    Clin Ther; 1993; 15(1):148-59. PubMed ID: 8458044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Fast-dissolving sublingual tablets of piroxicam versus naproxen in the treatment of recurrent acute osteoarthrosis. Multicenter clinical trial].
    Consoli G; Covelli M; Di Matteo L; Marcolongo R; Tirri G; La Montagna G; Pipitone V
    Minerva Med; 1994 Mar; 85(3):89-96. PubMed ID: 8196849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A new non-steroidal anti-inflammatory drug pirprofen (rengasil) in the treatment of rheumatoid arthritis and osteoarthrosis].
    Sigidin IaA; Pokryshkin VI
    Ter Arkh; 1987; 59(4):73-6. PubMed ID: 2954253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of piroxicam-beta-cyclodextrin sachets on abnormal postural sway in patients with chronic low back pain.
    Chang ST; Chen LC; Chang CC; Chu HY; Tsai KC
    J Clin Pharm Ther; 2008 Oct; 33(5):495-506. PubMed ID: 18834364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amtolmetin guacyl versus piroxicam in patients with osteoarthritis.
    Montrone F; Santandrea S; Caruso I; Gerli R; Cesarotti ME; Frediani P; Bassani R
    J Int Med Res; 2000; 28(2):91-100. PubMed ID: 10898121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of faecal blood loss, upper gastrointestinal mucosal integrity and symptoms after piroxicam beta-cyclodextrin, piroxicam and placebo administration.
    Patoia L; Clausi G; Farroni F; Alberti P; Fugiani P; Bufalino L
    Eur J Clin Pharmacol; 1989; 36(6):599-604. PubMed ID: 2673795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Supermolecular inclusion of piroxicam with beta-cyclodextrin: a review of its pharmacological properties in laboratory animals.
    Lister RE; Acerbi D; Cadel S
    Eur J Rheumatol Inflamm; 1993; 12(4):6-11. PubMed ID: 7805705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double-blind study of tenoxicam 20 mg versus piroxicam 20 mg in rheumatoid arthritis.
    Havranek H
    Eur J Rheumatol Inflamm; 1987; 9(2):105-8. PubMed ID: 3329099
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparative study of the occurrence of gastrointestinal side-effects of tenoxicam and other nonsteroidal antirheumatic agents in patients with rheumatoid arthritis].
    Vlak T; Jajić I; Bilić A
    Reumatizam; 1996; 43(1):1-9. PubMed ID: 8966374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical efficacy and tolerability of tenoxicam in African patients with osteoarthritis, rheumatoid arthritis, tendinitis and/or bursitis: an open study.
    Ibrahima K; Kodjo G; Issa S; Seye L; Cisse F; Eassey G; Rietiker S
    Curr Med Res Opin; 1991; 12(7):471-8. PubMed ID: 1778090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and efficacy of etodolac compared with piroxicam in patients with degenerative joint disease of the knee.
    Dick WC; Bulstra S; Schardijn GH; Feenstra RM
    Clin Ther; 1992; 14(4):517-26. PubMed ID: 1388092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Placebo-controlled comparison of piroxicam-beta-cyclodextrin, piroxicam, and indomethacin on gastric potential difference and mucosal injury in humans.
    Santucci L; Fiorucci S; Chiucchiù S; Sicilia A; Bufalino L; Morelli A
    Dig Dis Sci; 1992 Dec; 37(12):1825-32. PubMed ID: 1473431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.